跳至主要内容
临床试验/TCTR20160601003
TCTR20160601003Enrolling By Invitation1 期

Effect of Folic Acid therapy on Homocysteine Level in patients with Atherosclerosis or Buerger’s Disease and in Healthy individuals: A Nonrandomized clinical trial study

none0 个研究点目标入组 66 人开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
Enrolling By Invitation
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 75 Years(—)
性别
All

入选标准

  • buerger disease patients have Shionoya criteria and atherosclerosis was proved by angiography

排除标准

  • The exclusion criteria were age under 18 years; alcohol consumption; recent use of methotrexate, trimethoprim, phenytoin, carbamazepine, or theophylline; and underlying diseases such as malignancy, systemic diseases, systemic lupus erythematosus, rheumatoid arthritis, and hypothyroidism. To minimize the possible interactions of confounding factors, vitamin B12, 1000 U/w, was intravenously administered to all of the participants one week prior to the study

研究者

发起方
none

相似试验